Key result
FDG PET/CT successfully distinguishes pulmonary artery angiosarcoma from bland pulmonary embolus.
Why the study?
Differentiating pulmonary artery angiosarcoma from pulmonary embolism using imaging modalities is clinically challenging.
Does 18F-FDG PET/CT help differentiate pulmonary artery angiosarcoma from pulmonary embolism in patients with suspected PE?
Case Report (n=1)
Does 18F-FDG PET/CT help differentiate pulmonary artery angiosarcoma from pulmonary embolism in patients with suspected PE?
18F-FDG PET/CT can be a useful imaging modality to differentiate pulmonary artery angiosarcoma from bland pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
May support 18F-FDG PET/CT in atypical PE cases; hypothesis-generating, requiring prospective validation before practice change.
Kessler et al. (2014) conducted a case report in Pulmonary artery angiosarcoma (n=1). 18F-FDG PET/CT vs. Enhanced chest CT was evaluated on Differentiation of malignant tumor from pulmonary embolus. 18F-FDG PET/CT successfully differentiated a metabolically active pulmonary artery angiosarcoma from a bland pulmonary embolus.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: